4.2. Aromatase Overexpression in Estrogen-Responsive Breast Cancer

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 22-22

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis

By Shu Limin  

Cancer and Metastasis Reviews, Vol. 29, Iss. 3, 2010-09 ,pp. : 483-502

Springer Publishing Company

Access to resources Recommend Favorite

Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts

By Nukatsuka Mamoru   Saito Hitoshi   Nakagawa Fumio   Abe Masaaki   Uchida Junji   Shibata Jiro   Matsuo Ken-ichi   Noguchi Shinzaburo   Kiniwa Mamoru  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Effect of the aromatase inhibitor vorozole on estrogen and progesterone receptor content of rat mammary carcinomas induced by 1-methyl-1-nitrosourea

By Knott K.K.  

Breast Cancer Research and Treatment, Vol. 70, Iss. 3, 2001-12 ,pp. : 171-183

Springer Publishing Company

Access to resources Recommend Favorite

Differential expression pattern of estrogen receptors, aromatase, and sulfotransferase in breast cancer tissue and corresponding lymph node metastases

By Gschwantler-Kaulich Daphne  

Tumor Biology, Vol. 32, Iss. 3, 2011-06 ,pp. : 501-508

Springer Publishing Company

Access to resources Recommend Favorite